Certara Investor Day Presentation Deck
Simcyp Platform, leading mechanistic biosimulation software
Built upon first principles of biology, chemistry
and pharmacology
օստաալ
Neuro-
degenerative
Immuno-
genicity
Oncology
COVID-19
Quantitative
Pharmacology (QSP)
ve Systems
PBPK
Simcyp
Mechanistic
Biosimulation
Platform
pharmacokinetics (PBPK)
Cardiac Safety
Physiologic
Safety and Toxicity
Pediatrics
Quantitative Systems
Toxicology & Safety
Animal
Mech DermA
●
18 of the top 20 biopharma companies by
R&D spend used the Simcyp Platform in 2021
• Used by 11 global regulatory agencies
Recipient of FDA cooperative R&D agreement,
6 FDA grants and 7 European grants
Drives both software and tech-driven consulting
●
Supported FDA approval of 85+ novel drugs
with more than 250 label claims
●
34
CERTARAView entire presentation